Details for New Drug Application (NDA): 206071
✉ Email this page to a colleague
The generic ingredient in METHOCARBAMOL is aspirin; methocarbamol. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; methocarbamol profile page.
Summary for 206071
Tradename: | METHOCARBAMOL |
Applicant: | Navinta Llc |
Ingredient: | methocarbamol |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 206071
Physiological Effect | Centrally-mediated Muscle Relaxation |
Medical Subject Heading (MeSH) Categories for 206071
Suppliers and Packaging for NDA: 206071
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
METHOCARBAMOL | methocarbamol | SOLUTION;IM-IV | 206071 | ANDA | Navinta LLC | 68475-002 | 68475-002-25 | 25 VIAL in 1 CARTON (68475-002-25) / 10 mL in 1 VIAL (68475-002-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;IM-IV | Strength | 1GM/10ML (100MG/ML) | ||||
Approval Date: | Nov 24, 2017 | TE: | AP | RLD: | No |
Complete Access Available with Subscription